Disease-associated proteins are thought to propagate along neuronal processes in neurodegenerative diseases. To detect disease-associated prion protein (PrP C reutzfeldt-Jakob disease (CJD) is a lethal and transmissible neurodegenerative disease. CJD has 3 major etiological forms: acquired, genetic, and the most frequent, sporadic. In sporadic CJD (sCJD), at least 6 different molecular subtypes are distinguished based on the polymorphism at codon 129 (methionine [M] or valine [V] ) of the prion protein gene (PRNP) and the type of proteinase K-resistant prion protein (PrP) fragments detected by Western blot. 1 Importantly, neuropathological examination, based on the analysis of the distribution of characteristic spongiform change and immunomorphology of disease-associated PrP (PrP Sc ), reliably allows the recognition of molecular subtypes. 2 Lesion profiles and clinical phenotypes are significantly different between molecular subtypes. 2 Interestingly, VV-2 and MV-2 cases show prominent involvement of subcortical areas, including the brainstem. 3 In acquired animal prion diseases, including scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, and chronic wasting disease in deer, the medulla oblongata is thought to be a location where PrP Sc reaches the central nervous system after being transported through the vagus nerve from the gastrointestinal tract. 4, 5 In humans, the detection of PrP Sc in the lymphoreticular system of the gastrointestinal tract supports the spreading concept from the periphery to the brain in variant CJD, which is associated with BSE. 6 Furthermore, Iacono et al have suggested that involvement of the dorsal motor nucleus of the vagal nerve might indicate an "environmental exposure" in sCJD. 7 Prion diseases are model disorders for other, more frequent, neurodegenerative conditions. Prion-like propagation of disease-associated α-synuclein and hierarchical involvement of brain regions is thought to be a central event in the pathogenesis of Parkinson disease (PD). 8 Interestingly, α-synuclein can be found in the gastrointestinal tract; therefore, the vagus nerve has been suggested as a route of α-synuclein spreading to the brain. 9 However, the direction of α-synuclein propagation in the vagus nerve is still debated. 10 In human prion disease, it has been suggested that accumulation of PrP Sc in the dorsal motor nucleus of the vagus nerve could be an indication for disease propagation outside of the brain. 7, 11 To expand previous findings,
we assessed the peripheral medullary segments of the vagus nerve in individuals suffering from sporadic and genetic forms of CJD.
Materials and Methods

Selection of the Cases
We recruited brain samples of definite CJD cases from 3 different cohorts. 
Neuropathology
Five-micrometer-thick slices from formalin-fixed, paraffin-embedded tissue blocks of the medulla oblongata were examined. Only those cases were included in the study where the peripheral (extracerebral and intracranial) segment of vagus nerve was present on Klüver-Barrera-stained sections (Fig 1A, B) . We first screened the sections using the 12F10 anti-PrP antibody (Epitope: aa. 142-160; 1:1,000; Cayman Chemical, Ann Arbor, MI). In addition, we evaluated the peripheral segment of the hypoglossal nerve as well as the hypoglossal nucleus, the nucleus ambiguus, and the dorsal motor nucleus of the vagal nerve for the presence of intraneuronal PrP deposits. For epitope retrieval, we applied autoclaving at 121 C for 10 minutes, immersion in 96% formic acid for 5 minutes, and treatment with proteinase K (5 μg/ml in 
Statistical Analysis
We used a chi-squared test to compare the frequencies of PrP Sc immunoreactivity in the vagus nerves among the different molecular subtypes of sCJD and gCJD cases.
Results
We screened a total of 405 sCJD and gCJD cases; 192 contained the peripheral segment of the vagus nerve at the level of the medulla oblongata. (only 2 cases with the E200K PRNP mutation) was associated with intraneuronal PrP Sc in the ipsilateral corresponding nuclei (Fig 2) , not all cases with intraneuronal PrP Sc in the nuclei contained simultaneous immunoreactivity in the corresponding nerves (Table 1) . The morphology of the immunoreactivity in the vagal nerve differed between CJD subtypes. In the VV-2 sCJD cases, we observed coarse aggregates within the extracerebral portion of the vagus nerve with all anti-PrP antibodies (see Fig 1) . In contrast, in the gCJD cases, the PrP Sc immunore- 
Discussion
We show here that in CJD, PrP Sc accumulates in the intracranial extracerebral segment of the vagus nerve. This finding expands previous observations on PrP Sc deposition in the dorsal motor nucleus of the vagus nerve. 7 We had no access to extracranial portions of the nerve or peripheral organs, except for 2 genetic cases that did not exhibit disease-associated PrP aggregates. Abnormal protein processing and propagation are a common denominator of neurodegenerative diseases. Peripheral involvement of the autonomic nervous system has been studied in PD, where peripheral α-synuclein aggregates have been detected throughout the body. 12 Previous studies demonstrated limited or no peripheral involvement in human sporadic CJD with only discrete PrP Sc deposits found in a few dorsal root ganglia, associated to Schwann cells of myelinated and unmyelinated fibers in the superficial peroneal nerve; 13 they were also identified adaxonally in posterior root nerve fibers, but no labeling of the enteric nervous system has been reported. 6, 14 Moreover, contrasting with α-synuclein in PD, the optic nerve does not show PrP Sc deposits in sCJD despite the involvement of further stations of the optic pathway. usually observed in this molecular subtype. The coarse morphology of PrP Sc aggregates in VV-2 CJD is somewhat different from the adaxonal and Schwann cell-associated morphologies described previously 13, 14 and may be associated with failure of either directional components of axonal transport. This morphology suggests similarities with α-synuclein deposits in PD, where the olfactory and gastrointestinal tract have been discussed as potential catalysts of α-synuclein misfolding and spread. 9 The involvement of sympathetic nerves in the process of neuroinvasion has been proposed in experimental scrapie. 16 In sCJD, involvement of peripheral organs, including the spleen and muscle 17 and dorsal roots, 14 has been interpreted as a spillover of cerebral PrP Sc or centrifugal spread. 14, 17 Whether PrP Sc in the vagus nerve moves centrifugally toward the periphery or is transported centripetally toward the brain is still unclear. Noteworthy is the observation of α-synuclein deposits in PD in further cranial nerves and their nuclei, 18, 19 arguing for the concept that α-synuclein accumulation in the brain can also spread to the periphery. Interestingly, the morphology with fine granular vagal PrP Sc deposits was distinct in gCJD and also resembled adaxonal deposition (see Fig 1I) . Although the accumulation of PrP Sc in gCJD cases with E200K and T188K PRNP mutations most likely starts in the central nervous system, rarely the E200K mutation can be associated with early peripheral neuropathy. [20] [21] [22] Together with recent reports on PRNP mutations associated with autonomic neuropathy and involvement of the gastrointestinal system, 23, 24 an out to inward direction of propagation can be also considered, at least in some cases. Because our study was retrospective and on archival tissue samples, there are inherent limitations. First, not all cases showed the segments of the vagus nerve emerging from the medulla oblongata and for some molecular subtypes the case numbers might be low; second, the entire course of the vagus nerve from the central nervous system to the periphery was not available; third, no peripheral organs innervated by the vagus had been systematically collected in our series; fourth, we could not evaluate specific autonomic symptoms or whether longer duration of illness was associated with more intense PrP Sc immunoreactivity;
and finally, we did not have the appropriate methodology to determine the anterograde or retrograde transport of PrP Sc . However, our study expands previous observations restricted to medullary nuclei 3, 7 and provides proof that PrP Sc accumulation not only represents a local phenomenon but also involves corresponding cranial nerves. Furthermore, we suggest that the morphologically diverse deposition of PrP Sc argues against a uniform propagation mechanism.
These observations have implications for studies on other neurodegenerative conditions sharing prionlike pathogenic mechanisms, including α-synucleinopathies. 
